Workflow
NASH(非酒精性脂肪性肝炎)
icon
Search documents
Madrigal Pharmaceuticals (MDGL) Update / Briefing Transcript
2025-05-13 13:00
Madrigal Pharmaceuticals (MDGL) Update / Briefing May 13, 2025 08:00 AM ET Speaker0 Good day. Thank you for standing by. Welcome to Montreal Pharmaceuticals' Residra Two Year Compensated Mascidrosis Data and EASL twenty twenty five Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. As a reminder, today's conference call is being recorded. I would now like to introduce Ms. Tina Ventura, Chief Investor Relat ...
Madrigal Pharmaceuticals(MDGL) - 2025 Q1 - Earnings Call Transcript
2025-05-01 12:00
Madrigal Pharmaceuticals (MDGL) Q1 2025 Earnings Call May 01, 2025 08:00 AM ET Company Participants Tina Ventura - Chief Investor Relations OfficerBill Sibold - CEO & DirectorMardi Dier - CFOAndrea Newkirk - Biotechnolgy Equity ResearchAkash Tewari - Managing DirectorLiisa Bayko - Managing DirectorMayank Mamtani - Senior Managing DirectorEmma Gutstein - Equity Research Associate Conference Call Participants Eliana Merle - AnalystRitu Baral - MD & Senior Biotechnology AnalystYasmeen Rahimi - Sr. Research Ana ...